Skip to main content
. Author manuscript; available in PMC: 2019 May 8.
Published in final edited form as: Lancet Haematol. 2018 Jul 30;5(9):e393–e402. doi: 10.1016/S2352-3026(18)30109-1

Figure 3: Sensitivity and specificity of ASC specks in peripheral blood plasma from patients with myelodysplastic syndromes.

Figure 3:

Receiver operating characteristic AUC analysis of glucose-adjusted log10-normalised ASC speck percentage in patients with lower-risk, higher-risk, or any myelodysplastic syndromes from the discovery and validation cohorts.

ASC=apoptosis-associated speck-like protein containing a CARD.

MDS=myelodysplastic syndromes. AUC=area under the curve.